TOTUOP
PRCT icon

Trustees of The University of Pennsylvania’s Procept Biorobotics PRCT Stock Holding History

Trustees of The University of Pennsylvania’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-90,914
Closed -$3.21M – 7
2023
Q2 		$3.21M Hold
90,914
– – 2.42% 5
2023
Q1 		$2.58M Hold
90,914
– – 2.52% 6
2022
Q4 		$3.78M Sell
90,914
-7,467
-8% -$321K 4.47% 4
2022
Q3 		$4.08M Buy
+98,381
New +$3.92M 5.39% 4

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trustees of The University of Pennsylvania's PRCT Position: Q3 2023 in Review

Trustees of The University of Pennsylvania sold out of Procept Biorobotics (PRCT) in Q3 2023, closing a stake of 90,914 shares — an estimated $3.21M sold.

Trustees of The University of Pennsylvania first reported a position in PRCT in Q3 2022 and held it in 4 quarters. The position peaked at $4.08M in Q3 2022. 127 funds tracked by Wall St. Rank hold PRCT as of Q3 2023.

  • Trustees of The University of Pennsylvania reported no remaining Procept Biorobotics position as of Q3 2023 after selling out during the quarter.
  • Trustees of The University of Pennsylvania sold 90,914 Procept Biorobotics shares in Q3 2023, an estimated $3.21M.
  • Trustees of The University of Pennsylvania first reported a position in Procept Biorobotics in Q3 2022 and held it in 4 quarters.
  • Trustees of The University of Pennsylvania's Procept Biorobotics position peaked at $4.08M in Q3 2022.
  • 127 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2023.

Based on Trustees of The University of Pennsylvania's 13F filing for Q3 2023, filed 14 Nov 2023.